Patents by Inventor Olav Bergheim
Olav Bergheim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160089255Abstract: Disclosed herein are embodiments of an occlusion device that can be delivered into the vascular system of a patient for inducing weight loss. The device can be formed from a body that can expand from a collapsed to an expanded position, where the body can be configured to at least partially occlude a blood vessel. Further, the device can comprise a first and second end joined by a center section. One of the ends can contain a retrieval element for easily removing the device from the patient.Type: ApplicationFiled: September 23, 2015Publication date: March 31, 2016Inventors: Olav Bergheim, William Cohn, Reynolds Delgado, Timothy Murphy, Chris Swain
-
Publication number: 20090076436Abstract: An implant has a tubular member with an inlet configured to receive fluid from an anterior chamber of an eye, an outlet configured to deliver fluid from the inlet to a physiological outflow pathway of the eye, and a lumen therebetween configured for substantially free flow of the fluid and which generally defines a flow axis. At the outlet of the tubular member is a distal deployable portion that has a compacted position and an expanded position. The deployable portion is configured to expand in the physiological outflow pathway of the eye and moves transversely when transitioning between the compacted and expanded positions about a pivot axis which is substantially perpendicular to the flow axis.Type: ApplicationFiled: May 4, 2005Publication date: March 19, 2009Applicant: GLAUKOS CORPORATIONInventors: Morteza Gharib, Hosheng Tu, Olav Bergheim
-
Publication number: 20080234624Abstract: An ocular disorder treatment implant includes an anchor and a therapeutic agent. The implant has a body with first and second end portions. The implant is configured to transport fluid from the anterior chamber of an eye to a physiological outflow pathway of the eye. The body has at least one inlet opening at the first end portion and at least one outlet opening at the second end portion such that the inlet and outlet openings are in fluid communication and define an axis therebetween. The anchor extends substantially perpendicularly to a part of the axis between the openings, and at least one outlet opening is configured to be positioned in the physiological outflow pathway. One implant has two outlet openings, and the anchor is disposed closer to one of the outlet openings.Type: ApplicationFiled: July 12, 2004Publication date: September 25, 2008Applicant: GLAUKOS CORPORATIONInventors: Olav Bergheim, Morteza Gharib
-
Publication number: 20080045878Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.Type: ApplicationFiled: August 20, 2007Publication date: February 21, 2008Applicant: GLAUKOS CORPORATIONInventors: Olav Bergheim, Morteza (Mory) Gharib
-
Publication number: 20070282244Abstract: A glaucoma treatment device for directing the flow of aqueous humor and bypassing trabecular meshwork is shown. The device includes an inlet section, an outlet section, a middle section, and at least one lumen for transmitting aqueous humor within the glaucoma device. The lumen extends through at least one of the sections, and the outlet section is substantially perpendicular to the middle section and fits within a conduit of aqueous humor outflow in the eye.Type: ApplicationFiled: August 8, 2007Publication date: December 6, 2007Applicant: GLAUKOS CORPORATIONInventors: Hosheng Tu, Olav Bergheim, Morteza Gharib
-
Publication number: 20060195055Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.Type: ApplicationFiled: April 27, 2006Publication date: August 31, 2006Inventors: Olav Bergheim, Morteza (Mory) Gharib
-
Publication number: 20060195056Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.Type: ApplicationFiled: April 27, 2006Publication date: August 31, 2006Inventors: Olav Bergheim, Morteza Gharib
-
Publication number: 20060084907Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.Type: ApplicationFiled: December 6, 2005Publication date: April 20, 2006Inventors: Olav Bergheim, Morteza Gharib
-
Publication number: 20060074375Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.Type: ApplicationFiled: December 6, 2005Publication date: April 6, 2006Inventors: Olav Bergheim, Morteza (Mory) Gharib
-
Patent number: 6981958Abstract: A trabecular shunt and methods for treating glaucoma are disclosed. One of the methods comprises transporting fluid from the anterior chamber of an eye to Schlemm's canal through an implant, the implant extending between the anterior chamber and Schlemm's canal; sensing an intraocular pressure using a sensor incorporated into the implant; and transmitting a signal indicative of the sensed pressure to an external receiver.Type: GrantFiled: July 24, 2003Date of Patent: January 3, 2006Assignee: Glaukos CorporationInventors: Morteza Gharib, Hosheng Tu, Olav Bergheim
-
Publication number: 20050288619Abstract: A trabecular shunt and methods for treating glaucoma are disclosed. One of the methods comprises transporting fluid from the anterior chamber of an eye to Schlemm's canal through an implant, the implant extending between the anterior chamber and Schlemm's canal; sensing an intraocular pressure using a sensor incorporated into the implant; and transmitting a signal indicative of the sensed pressure to an external receiver.Type: ApplicationFiled: August 23, 2005Publication date: December 29, 2005Inventors: Morteza Gharib, Hosheng Tu, Olav Bergheim
-
Publication number: 20050209549Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.Type: ApplicationFiled: May 6, 2005Publication date: September 22, 2005Inventors: Olav Bergheim, Morteza (Mory) Gharib
-
Publication number: 20050209550Abstract: Surgical methods and related medical devices for treating glaucoma are disclosed. The method comprises trabecular bypass surgery, which involve bypassing diseased trabecular meshwork with the use of a seton implant. The seton implant is used to prevent a healing process known as filling in, which has a tendency to close surgically created openings in the trabecular meshwork. The surgical method and novel implant are addressed to the trabecular meshwork, which is a major site of resistance to outflow in glaucoma. In addition to bypassing the diseased trabecular meshwork at the level of the trabecular meshwork, existing outflow pathways are also used or restored. The seton implant is positioned through the trabecular meshwork so that an inlet end of the seton implant is exposed to the anterior chamber of the eye and an outlet end is positioned into fluid collection channels at about an exterior surface of the trabecular meshwork or up to the level of aqueous veins.Type: ApplicationFiled: May 6, 2005Publication date: September 22, 2005Inventors: Olav Bergheim, Morteza Gharib
-
Publication number: 20050192527Abstract: A trabecular shunt and methods for treating glaucoma are disclosed. One of the methods comprises transporting fluid from the anterior chamber of an eye to Schlemm's canal through an implant, the implant extending between the anterior chamber and Schlemm's canal; sensing an intraocular pressure using a sensor incorporated into the implant; and transmitting a signal indicative of the sensed pressure to an external receiver.Type: ApplicationFiled: May 4, 2005Publication date: September 1, 2005Inventors: Morteza Gharib, Hosheng Tu, Olav Bergheim
-
Patent number: 6666841Abstract: A trabecular shunt and methods for treating glaucoma are disclosed. The method comprises placing a trabecular shunt through diseased trabecular meshwork, between the anterior chamber and Schlemm's canal. The trabecular shunt includes a hollow, elongated tubular element having an inlet section and an outlet section. The outlet section includes two bifurcatable elements adapted to be positioned and stabilized inside Schlemm's canal.Type: GrantFiled: May 2, 2001Date of Patent: December 23, 2003Assignee: Glaukos CorporationInventors: Morteza Gharib, Hosheng Tu, Olav Bergheim
-
Publication number: 20030060752Abstract: A glaucoma treatment device for directing the flow of aqueous humor and reducing intraocular pressure for angle closure glaucoma is disclosed. The glaucoma device comprises an aqueous transporting element for transporting aqueous humor to bypass dysfunctional anatomical iris closure and restoring existing outflow pathways of the anatomical iris closure. The aqueous transporting element has an inlet end and an outlet end, wherein the inlet end is positioned inside an anterior chamber of an eye beyond an edge of the dysfunctional anatomic iris closure and the outlet end is positioned in proximity of trabecular meshwork of the eye. The device also serves to stent the space between the iris and an inner surface of a cornea of the eye.Type: ApplicationFiled: May 1, 2002Publication date: March 27, 2003Inventors: Olav Bergheim, Hosheng Tu, Morteza Gharib
-
Publication number: 20020165478Abstract: A trabecular shunt and methods for treating glaucoma are disclosed. The method comprises placing a trabecular shunt through diseased trabecular meshwork, between the anterior chamber and Schlemm's canal. The trabecular shunt includes a hollow, elongated tubular element having an inlet section and an outlet section. The outlet section includes two bifurcatable elements adapted to be positioned and stabilized inside Schlemm's canal.Type: ApplicationFiled: May 2, 2001Publication date: November 7, 2002Inventors: Morteza Gharib, Hosheng Tu, Olav Bergheim
-
Publication number: 20010007940Abstract: An improved ultrasound device system comprising an ultrasound transducer at about a distal section of an elongate apparatus, wherein the ultrasound transducer comprises the capabilities of ultrasound imaging, RF thermal therapy, cryogenic therapy and temperature sensing for effective treating the tissue or lesion.Type: ApplicationFiled: March 2, 2001Publication date: July 12, 2001Inventors: Hosheng Tu, Olav Bergheim